AR and prostate carcinoma: In prostate cancer cells (PC3) and PC3 mouse xenografts, EGCG blocked nuclear translocation and protein expression of androgen receptor (implicated in prostate cancer etiology), and these effects were associated with the down-regulation of androgen-regulated miRNA-21 and up-regulation of miRNA-330, a tumor suppressor [204].